Biomarkers & Combination Therapy May Be the Path Ahead for Immunotherapy - 102126

Spotlight
Video

Biomarkers & Combination Therapy May Be the Path Ahead for Immunotherapy

Loading........
Description: Ezra E.W. Cohen, MD of University of California, San Diego explains how biomarkers and combination therapy may be the path ahead for immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Shared By : AnnualMeeting-SITC2017
Posted on : 03/06/17
Added : 2 years ago
Category : Immunotherapy